RecruitingPhase 2NCT05511246

Venous Ethanol for Ventricular Tachycardia

Venous Ethanol for Ischemic Left Ventricular Tachycardia


Sponsor

The Methodist Hospital Research Institute

Enrollment

156 participants

Start Date

Apr 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Catheter ablation and a drug called Venous ethanol for people with ischemic cardiomyopathy and ventricular tachycardia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVenous ethanol

Cannulation of coronary vein or veins in the VT substrate and balloon injection of ethanol

PROCEDURECatheter ablation

Endocardial catheter ablation of VT substrate


Locations(1)

Houston Methodist Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05511246


Related Trials